Clinicopathological impact of anti-smooth muscle antibodies in patients with non-alcoholic fatty liver disease
暂无分享，去创建一个
H. Elalfy | M. Arafa | W. Elkashef | S. M. Abo El-Khair | A. Elsamanoudy | M. Mohamed | M. A. El-Maksoud | K. Zalata | R. Farag | S. Abed | M. EL AZIZ | S. M. Abo El-khair